1. Home
  2. PDSB vs ELUT Comparison

PDSB vs ELUT Comparison

Compare PDSB & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDSB
  • ELUT
  • Stock Information
  • Founded
  • PDSB 2005
  • ELUT 2015
  • Country
  • PDSB United States
  • ELUT United States
  • Employees
  • PDSB N/A
  • ELUT N/A
  • Industry
  • PDSB Biotechnology: Pharmaceutical Preparations
  • ELUT Medical Specialities
  • Sector
  • PDSB Health Care
  • ELUT Health Care
  • Exchange
  • PDSB Nasdaq
  • ELUT Nasdaq
  • Market Cap
  • PDSB 72.2M
  • ELUT 85.5M
  • IPO Year
  • PDSB N/A
  • ELUT 2020
  • Fundamental
  • Price
  • PDSB $1.19
  • ELUT $2.14
  • Analyst Decision
  • PDSB Strong Buy
  • ELUT Strong Buy
  • Analyst Count
  • PDSB 2
  • ELUT 2
  • Target Price
  • PDSB $10.00
  • ELUT $8.00
  • AVG Volume (30 Days)
  • PDSB 544.6K
  • ELUT 29.3K
  • Earning Date
  • PDSB 08-12-2025
  • ELUT 08-06-2025
  • Dividend Yield
  • PDSB N/A
  • ELUT N/A
  • EPS Growth
  • PDSB N/A
  • ELUT N/A
  • EPS
  • PDSB N/A
  • ELUT N/A
  • Revenue
  • PDSB N/A
  • ELUT $23,711,000.00
  • Revenue This Year
  • PDSB N/A
  • ELUT $20.10
  • Revenue Next Year
  • PDSB N/A
  • ELUT $85.89
  • P/E Ratio
  • PDSB N/A
  • ELUT N/A
  • Revenue Growth
  • PDSB N/A
  • ELUT N/A
  • 52 Week Low
  • PDSB $0.85
  • ELUT $1.61
  • 52 Week High
  • PDSB $4.32
  • ELUT $5.12
  • Technical
  • Relative Strength Index (RSI)
  • PDSB 39.96
  • ELUT 51.77
  • Support Level
  • PDSB $1.02
  • ELUT $1.76
  • Resistance Level
  • PDSB $1.28
  • ELUT $2.41
  • Average True Range (ATR)
  • PDSB 0.11
  • ELUT 0.24
  • MACD
  • PDSB -0.01
  • ELUT -0.02
  • Stochastic Oscillator
  • PDSB 47.61
  • ELUT 37.50

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

Share on Social Networks: